CFAP410 and amyotrophic lateral sclerosis: These are at most weak risk variants, with varying evidence of association with ALS, the strongest being for CFAP410 V58L and KIF5A P986L, both of which are significant GWAS hits, with the potential to be direct effectors of increased ALS risk [39].